Please try another search
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of nervous system related, infectious, gastrointestinal, urinary system, and autoimmune diseases. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.
Name | Age | Since | Title |
---|---|---|---|
Hongshan Zhang | 59 | 2018 | Chairman of Supervisory Board |
Rong Qin Zhang | 55 | 2013 | Non-Independent Director |
Ying Sun | 61 | 2018 | Independent Director |
Lianchun Yang | 58 | 2021 | Non-Independent Director |
Li Zhao | 66 | 2021 | Independent Director |
Jiajun Zhao | 62 | 2021 | Independent Director |
Zhi Wen Zhou | 58 | - | Chairman |
Tao Li | 60 | 2011 | Supervisor |
Xiaoyan Wang | 47 | - | Director |
Hong Zheng | 52 | - | Employee Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review